Return to homepagePandemic Pact

Development and Production of Immunological Methods for the Detection of Sars-Cov2 Virus and Specific Antibodies in Serum of Mexican Patients With Covid-19.

  • Funded by Consejo Nacional de Ciencia y Tecnología (CONACYT)
  • Total publications:3 publications

Grant number: 311783

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    N/A

  • Known Financial Commitments (USD)

    $0

  • Funder

    Consejo Nacional de Ciencia y Tecnología (CONACYT)

  • Principal Investigator

    N/A

  • Research Location

    Mexico

  • Lead Research Institution

    N/A

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Diagnostics

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Development And Validation Of Diagnostic Or Prognostic Tools, Sensitive And Specific

3 Publications linked via Europe PMC

Last Updated:6 days ago

View all publications at Europe PMC

Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19.

Common hematological values predict unfavorable outcomes in hospitalized COVID-19 patients.

A parallel-group, multicenter randomized, double-blinded, placebo-controlled, phase 2/3, clinical trial to test the efficacy of pyridostigmine bromide at low doses to reduce mortality or invasive mechanical ventilation in adults with severe SARS-CoV-2 infection: the Pyridostigmine In Severe COvid-19 (PISCO) trial protocol.